These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28154014)

  • 1. A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity.
    Kaltenmeier CT; Vollmer LL; Vernetti LA; Caprio L; Davis K; Korotchenko VN; Day BW; Tsang M; Hulkower KI; Lotze MT; Vogt A
    J Pharmacol Exp Ther; 2017 Apr; 361(1):39-50. PubMed ID: 28154014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
    Ramkissoon A; Chaney KE; Milewski D; Williams KB; Williams RL; Choi K; Miller A; Kalin TV; Pressey JG; Szabo S; Azam M; Largaespada DA; Ratner N
    Clin Cancer Res; 2019 Jul; 25(13):4117-4127. PubMed ID: 30936125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase.
    Cadalbert L; Sloss CM; Cameron P; Plevin R
    Cell Signal; 2005 Oct; 17(10):1254-64. PubMed ID: 16038800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
    Reffas S; Schlegel W
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of mitogen-activated protein kinase inhibition by parathyroid hormone in osteoblast-like cells.
    Hömme M; Schmitt CP; Mehls O; Schaefer F
    J Am Soc Nephrol; 2004 Nov; 15(11):2844-50. PubMed ID: 15504937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of MAP kinase activation by a novel splice variant of human MAP kinase phosphatase-2.
    Cadalbert LC; Sloss CM; Cunningham MR; Al-Mutairi M; McIntire A; Shipley J; Plevin R
    Cell Signal; 2010 Mar; 22(3):357-65. PubMed ID: 19843478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes.
    Henklova P; Vrzal R; Papouskova B; Bednar P; Jancova P; Anzenbacherova E; Ulrichova J; Maurel P; Pavek P; Dvorak Z
    Eur J Pharmacol; 2008 Sep; 593(1-3):16-23. PubMed ID: 18655782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCI, an inhibitor of the DUSP1 and DUSP6 dual specificity phosphatases, enhances P2X7 receptor expression in neuroblastoma cells.
    Benito-León M; Gil-Redondo JC; Perez-Sen R; Delicado EG; Ortega F; Gomez-Villafuertes R
    Front Cell Dev Biol; 2022; 10():1049566. PubMed ID: 36589747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer.
    Wu GS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):579-85. PubMed ID: 17717636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not.
    Mohamed AA; Jupp OJ; Anderson HM; Littlejohn AF; Vandenabeele P; MacEwan DJ
    Biochem J; 2002 Aug; 366(Pt 1):145-55. PubMed ID: 11996667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-specificity MAP kinase phosphatases as targets of cancer treatment.
    Nunes-Xavier C; Romá-Mateo C; Ríos P; Tárrega C; Cejudo-Marín R; Tabernero L; Pulido R
    Anticancer Agents Med Chem; 2011 Jan; 11(1):109-32. PubMed ID: 21288197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes.
    Lee YJ; Shukla SD
    Eur J Pharmacol; 2005 Jan; 508(1-3):31-45. PubMed ID: 15680252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual specificity phosphatases 10 and 16 are positive regulators of EGF-stimulated ERK activity: indirect regulation of ERK signals by JNK/p38 selective MAPK phosphatases.
    Finch AR; Caunt CJ; Perrett RM; Tsaneva-Atanasova K; McArdle CA
    Cell Signal; 2012 May; 24(5):1002-11. PubMed ID: 22245064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaffold Role of DUSP22 in ASK1-MKK7-JNK Signaling Pathway.
    Ju A; Cho YC; Kim BR; Park SG; Kim JH; Kim K; Lee J; Park BC; Cho S
    PLoS One; 2016; 11(10):e0164259. PubMed ID: 27711255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.